{"entity":{"type":"insider","cik":"0001588438","url":"/insider/0001588438","json_url":"/insider/0001588438.json","name":"Shacham Sharon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":80,"n_filings":54,"first":"2014-06-19","last":"2022-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Shacham Sharon","source":"filing","n_filings":54,"first_seen":"2014-06-19","last_seen":"2022-03-02"}],"transactions":[{"id":6447906,"accession":"0001209191-22-014626","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-014626","line_url":"/filing/0001209191-22-014626","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12452.0,"shares_display":"12,452","price_per_share":10.2375,"price_display":"10.24","price_state":"stated","total_value":127477.35,"total_display":"127,477.35","total_whole":"127,477","shares_owned_after":898131.0,"shares_owned_after_display":"898,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider","n_lines":2},{"id":6722977,"accession":"0001209191-22-011639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-011639","line_url":"/filing/0001209191-22-011639","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18167.0,"shares_display":"18,167","price_per_share":12.1234,"price_display":"12.12","price_state":"stated","total_value":220245.8078,"total_display":"220,245.81","total_whole":"220,246","shares_owned_after":904357.0,"shares_owned_after_display":"904,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider","n_lines":2},{"id":6777106,"accession":"0001209191-22-008119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008119","line_url":"/filing/0001209191-22-008119","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13471.0,"shares_display":"13,471","price_per_share":9.862,"price_display":"9.86","price_state":"stated","total_value":132851.002,"total_display":"132,851.00","total_whole":"132,851","shares_owned_after":708062.0,"shares_owned_after_display":"708,062","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":2},{"id":5379509,"accession":"0001209191-21-022487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-022487","line_url":"/filing/0001209191-21-022487#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.3882,"price_display":"12.39","price_state":"stated","total_value":49552.8,"total_display":"49,552.80","total_whole":"49,553","shares_owned_after":714826.0,"shares_owned_after_display":"714,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-23","scope":"insider"},{"id":4773880,"accession":"0001209191-21-012964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012964","line_url":"/filing/0001209191-21-012964","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18990.0,"shares_display":"18,990","price_per_share":14.8312,"price_display":"14.83","price_state":"stated","total_value":281644.488,"total_display":"281,644.49","total_whole":"281,644","shares_owned_after":776452.0,"shares_owned_after_display":"776,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-22","scope":"insider","n_lines":2},{"id":4137911,"accession":"0001209191-21-011486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011486","line_url":"/filing/0001209191-21-011486","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13243.0,"shares_display":"13,243","price_per_share":15.519,"price_display":"15.52","price_state":"stated","total_value":205518.117,"total_display":"205,518.12","total_whole":"205,518","shares_owned_after":764147.0,"shares_owned_after_display":"764,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-17","scope":"insider","n_lines":2},{"id":2588300,"accession":"0001209191-20-054821","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-054821","line_url":"/filing/0001209191-20-054821#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":14.891,"price_display":"14.89","price_state":"stated","total_value":111682.5,"total_display":"111,682.50","total_whole":"111,683","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-14","scope":"insider"},{"id":2443378,"accession":"0001209191-20-047278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047278","line_url":"/filing/0001209191-20-047278#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1477.0,"shares_display":"1,477","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":22155.0,"total_display":"22,155.00","total_whole":"22,155","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":3115770,"accession":"0001209191-20-042840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042840","line_url":"/filing/0001209191-20-042840#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.4297,"price_display":"19.43","price_state":"stated","total_value":145722.75,"total_display":"145,722.75","total_whole":"145,723","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":2832847,"accession":"0001209191-20-042309","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-042309","line_url":"/filing/0001209191-20-042309","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.005228,"price_display":"19.01","price_state":"stated","total_value":142539.21,"total_display":"142,539.21","total_whole":"142,539","shares_owned_after":555422.0,"shares_owned_after_display":"555,422","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-13","scope":"insider","n_lines":2},{"id":2832839,"accession":"0001209191-20-042309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042309","line_url":"/filing/0001209191-20-042309#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.5316,"price_display":"19.53","price_state":"stated","total_value":146487.0,"total_display":"146,487.00","total_whole":"146,487","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-13","scope":"insider"},{"id":2287434,"accession":"0001209191-20-038717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038717","line_url":"/filing/0001209191-20-038717#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"},{"id":2544861,"accession":"0001209191-20-037226","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-037226","line_url":"/filing/0001209191-20-037226","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":16.37057484,"price_display":"16.37","price_state":"stated","total_value":122779.3113,"total_display":"122,779.31","total_whole":"122,779","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider","n_lines":2},{"id":2730574,"accession":"0001209191-20-035943","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-035943","line_url":"/filing/0001209191-20-035943#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.1259,"price_display":"18.13","price_state":"stated","total_value":135944.25,"total_display":"135,944.25","total_whole":"135,944","shares_owned_after":555122.0,"shares_owned_after_display":"555,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-11","scope":"insider"},{"id":2730565,"accession":"0001209191-20-035943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-035943","line_url":"/filing/0001209191-20-035943#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.4994,"price_display":"18.50","price_state":"stated","total_value":138745.5,"total_display":"138,745.50","total_whole":"138,746","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-11","scope":"insider"},{"id":2110487,"accession":"0001209191-20-030611","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-030611","line_url":"/filing/0001209191-20-030611#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-19","scope":"insider"},{"id":2110485,"accession":"0001209191-20-030611","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-030611","line_url":"/filing/0001209191-20-030611#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.6454,"price_display":"18.65","price_state":"stated","total_value":139840.5,"total_display":"139,840.50","total_whole":"139,841","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider"},{"id":2543747,"accession":"0001209191-20-028263","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-028263","line_url":"/filing/0001209191-20-028263","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":19.6276,"price_display":"19.63","price_state":"stated","total_value":294414.0,"total_display":"294,414.00","total_whole":"294,414","shares_owned_after":555122.0,"shares_owned_after_display":"555,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider","n_lines":2},{"id":3040049,"accession":"0001209191-20-024147","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-024147","line_url":"/filing/0001209191-20-024147#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.6404,"price_display":"20.64","price_state":"stated","total_value":206404.0,"total_display":"206,404.00","total_whole":"206,404","shares_owned_after":555122.0,"shares_owned_after_display":"555,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-10","scope":"insider"},{"id":3040037,"accession":"0001209191-20-024147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-024147","line_url":"/filing/0001209191-20-024147#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.6115,"price_display":"18.61","price_state":"stated","total_value":186115.0,"total_display":"186,115.00","total_whole":"186,115","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":2878372,"accession":"0001209191-20-018260","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-018260","line_url":"/filing/0001209191-20-018260","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.21859692,"price_display":"22.22","price_state":"stated","total_value":222185.9692,"total_display":"222,185.97","total_whole":"222,186","shares_owned_after":557190.0,"shares_owned_after_display":"557,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-11","scope":"insider","n_lines":2},{"id":2878360,"accession":"0001209191-20-018260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-018260","line_url":"/filing/0001209191-20-018260","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.51946,"price_display":"22.52","price_state":"stated","total_value":225194.6,"total_display":"225,194.60","total_whole":"225,195","shares_owned_after":759489.0,"shares_owned_after_display":"759,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider","n_lines":2},{"id":2487724,"accession":"0001209191-20-011690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-011690","line_url":"/filing/0001209191-20-011690","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17634.0,"shares_display":"17,634","price_per_share":16.4819,"price_display":"16.48","price_state":"stated","total_value":290641.8246,"total_display":"290,641.82","total_whole":"290,642","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider","n_lines":2},{"id":2137576,"accession":"0001209191-20-008729","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-008729","line_url":"/filing/0001209191-20-008729#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.4294,"price_display":"17.43","price_state":"stated","total_value":174294.0,"total_display":"174,294.00","total_whole":"174,294","shares_owned_after":542139.0,"shares_owned_after_display":"542,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":2137572,"accession":"0001209191-20-008729","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008729","line_url":"/filing/0001209191-20-008729#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.9327,"price_display":"16.93","price_state":"stated","total_value":169327.0,"total_display":"169,327.00","total_whole":"169,327","shares_owned_after":743506.0,"shares_owned_after_display":"743,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":2817448,"accession":"0001209191-20-003086","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-003086","line_url":"/filing/0001209191-20-003086#line-6","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.188,"price_display":"19.19","price_state":"stated","total_value":191880.0,"total_display":"191,880.00","total_whole":"191,880","shares_owned_after":542139.0,"shares_owned_after_display":"542,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-10","scope":"insider"},{"id":2817438,"accession":"0001209191-20-003086","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-003086","line_url":"/filing/0001209191-20-003086#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.5705,"price_display":"18.57","price_state":"stated","total_value":185705.0,"total_display":"185,705.00","total_whole":"185,705","shares_owned_after":743506.0,"shares_owned_after_display":"743,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":8011427,"accession":"0001209191-19-060072","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060072","line_url":"/filing/0001209191-19-060072#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.9896,"price_display":"15.99","price_state":"stated","total_value":159896.0,"total_display":"159,896.00","total_whole":"159,896","shares_owned_after":529767.0,"shares_owned_after_display":"529,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":8011421,"accession":"0001209191-19-060072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060072","line_url":"/filing/0001209191-19-060072#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.021,"price_display":"17.02","price_state":"stated","total_value":170210.0,"total_display":"170,210.00","total_whole":"170,210","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7980696,"accession":"0001209191-19-056027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-056027","line_url":"/filing/0001209191-19-056027#line-4","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.761,"price_display":"14.76","price_state":"stated","total_value":147610.0,"total_display":"147,610.00","total_whole":"147,610","shares_owned_after":529767.0,"shares_owned_after_display":"529,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-12","scope":"insider"},{"id":7980690,"accession":"0001209191-19-056027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056027","line_url":"/filing/0001209191-19-056027#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.6254,"price_display":"14.63","price_state":"stated","total_value":146254.0,"total_display":"146,254.00","total_whole":"146,254","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-12","scope":"insider"},{"id":8167950,"accession":"0001209191-19-055170","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-055170","line_url":"/filing/0001209191-19-055170","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-05","scope":"insider","n_lines":2},{"id":7980188,"accession":"0001209191-19-049868","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049868","line_url":"/filing/0001209191-19-049868","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-17","scope":"insider","n_lines":2},{"id":8411212,"accession":"0001209191-19-003059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003059","line_url":"/filing/0001209191-19-003059#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":10.2259,"price_display":"10.23","price_state":"stated","total_value":127823.75,"total_display":"127,823.75","total_whole":"127,824","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"},{"id":6238921,"accession":"0001209191-18-061765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061765","line_url":"/filing/0001209191-18-061765#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":10.1138,"price_display":"10.11","price_state":"stated","total_value":126422.5,"total_display":"126,422.50","total_whole":"126,423","shares_owned_after":713510.0,"shares_owned_after_display":"713,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-10","scope":"insider"},{"id":6427115,"accession":"0001209191-18-059990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-059990","line_url":"/filing/0001209191-18-059990#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":105600.0,"total_display":"105,600.00","total_whole":"105,600","shares_owned_after":512143.0,"shares_owned_after_display":"512,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-26","filed_date":"2018-11-27","scope":"insider"},{"id":6635508,"accession":"0001209191-18-059621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-059621","line_url":"/filing/0001209191-18-059621#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001588438","owner_name":"Shacham Sharon","owner_display_name":"Shacham Sharon","owner_url":"/insider/0001588438","role":"Officer (President & CSO)","role_mark":"O","role_mark_label":"Officer (President & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":11.1363,"price_display":"11.14","price_state":"stated","total_value":4454.52,"total_display":"4,454.52","total_whole":"4,455","shares_owned_after":512143.0,"shares_owned_after_display":"512,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2018-11-21","scope":"insider"}],"collapsed":true,"next_cursor":"2018-11-19|6635508","ledger_fault":false,"count":{"value":80,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":80,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":80},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (Chief Scientific Officer)","n_filings":54,"first_seen":"2014-06-19","last_seen":"2022-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001588438","retrieved_at":"2026-08-24T03:21:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}